CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-31 | McCarthy Sean A. President and CEO | Grant or award | +302 | $17.90 | $5K | 4,945 |
| 2018-05-01 | RAY DEBANJAN Chief Financial Officer | Option exercise | +3,000 | $1.26 | $4K | 7,741 |
| 2018-05-01 | RAY DEBANJAN Chief Financial Officer | Sale | −3,000 | $26.52 | $80K | 4,741 |
| 2018-05-01 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 8,710 | ||
| 2018-05-01 | McCarthy Sean A. President and CEO | Option exercise | +19,578 | $1.57 | $31K | 24,221 |
| 2018-05-01 | McCarthy Sean A. President and CEO | Sale | −19,578 | $26.55 | $520K | 4,643 |
| 2018-05-01 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −19,578 | 175,226 | ||
| 2018-04-02 | RAY DEBANJAN Chief Financial Officer | Option exercise | +3,000 | $1.26 | $4K | 7,741 |
| 2018-04-02 | RAY DEBANJAN Chief Financial Officer | Sale | −3,000 | $28.12 | $84K | 4,741 |
| 2018-04-02 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 11,710 | ||
| 2018-03-26 | GLUCK FREDERICK W Director | Sale | −5,000 | $31.93 | $160K | 271,643 |
| 2018-03-02 | GLUCK FREDERICK W Director | Sale | −16,181 | $30.00 | $485K | 276,643 |
| 2018-03-02 | HUMPHREY RACHEL Chief Medical Officer | Option exercise | +16,160 | $6.61 | $107K | 46,394 |
| 2018-03-02 | HUMPHREY RACHEL Chief Medical Officer | Sale | −16,160 | $30.00 | $485K | 30,234 |
| 2018-03-02 | HUMPHREY RACHEL Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −16,160 | 222,980 | ||
| 2018-03-02 | RAY DEBANJAN Chief Financial Officer | Option exercise | +5,515 | $1.26 | $7K | 10,256 |
| 2018-03-02 | RAY DEBANJAN Chief Financial Officer | Sale | −5,515 | $30.06 | $166K | 4,741 |
| 2018-03-02 | RAY DEBANJAN Chief Financial Officer | Option exercise | +14,485 | $1.13 | $16K | 19,226 |
| 2018-03-02 | RAY DEBANJAN Chief Financial Officer | Sale | −12,541 | $30.41 | $381K | 6,685 |
| 2018-03-02 | RAY DEBANJAN Chief Financial Officer | Sale | −1,944 | $31.02 | $60K | 4,741 |
Page 19 of 33 · 649 trades